Measuring Ultrasound Guided Skeletal Muscle Mass of Lower Extremity as a Predictor of Post-Operative Length of Stay in Exploratory Gynae-oncology Surgeries

Sponsor
Tata Medical Center
Study ID
NCT06816836
Status
Recruiting
Apply to this trial

Conditions

  • Frailty
  • Gynecologic Cancer
  • Sarcopenia

Eligibility Criteria

Sex
FEMALE
Age
50 Years - 99 Years
Healthy Volunteers
Not accepted

Interventions

  • Bed Side ultrasound guided muscle mass estimation of lower extremity — PROCEDURE
    Bed Side ultrasound guided muscle mass estimation of psoas major, rectus femoris, vastus intermedius and tibialis anterior.

Study Details

Increased incidence of Gynae-oncological cancer is observed specifically in women above 50 years of age. Sarcopenia (a progressive and generalized loss of skeletal muscle mass, quality, and strength) is considered a reliable indicator of frailty, a poor prognostic factor in these patients. Various frailty scores and measurement of psoas muscle mass are time consuming, can't be done in patients unable to walk and altered mental status. The investigators wanted to evaluate if bedside ultrasound guided skeletal muscle measurement, as a measure of sarcopenia, can be used to predict post operative length of stay.

Key Dates

First listed
Feb 10, 2025
Start date
Apr 1, 2025
Status verified
May 2025
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
320 participants (estimated)

Arms

  • Arm: GC Patients, CCI Score 3+
    All consecutive consenting Gynecological Cancer patients above 50 years of age undergoing open surgical intervention, with Charlson Co-morbidity Index score of 3 or more.

Primary Outcome Measure

Prolonged length of hospital stay [ Time Frame: 3 Years ]

Related Studies